ATE477320T1 - Methoden zur virus-reinigung - Google Patents

Methoden zur virus-reinigung

Info

Publication number
ATE477320T1
ATE477320T1 AT06006494T AT06006494T ATE477320T1 AT E477320 T1 ATE477320 T1 AT E477320T1 AT 06006494 T AT06006494 T AT 06006494T AT 06006494 T AT06006494 T AT 06006494T AT E477320 T1 ATE477320 T1 AT E477320T1
Authority
AT
Austria
Prior art keywords
cleaning methods
virus cleaning
virus
methods
purifying
Prior art date
Application number
AT06006494T
Other languages
English (en)
Inventor
John Tang
Gary J Vellekamp
Laureano L Bondoc
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE477320T1 publication Critical patent/ATE477320T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10051—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06006494T 1996-12-13 1997-12-11 Methoden zur virus-reinigung ATE477320T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76683596A 1996-12-13 1996-12-13

Publications (1)

Publication Number Publication Date
ATE477320T1 true ATE477320T1 (de) 2010-08-15

Family

ID=25077670

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97950805T ATE353956T1 (de) 1996-12-13 1997-12-11 Methoden zur virus-reinigung
AT06006494T ATE477320T1 (de) 1996-12-13 1997-12-11 Methoden zur virus-reinigung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97950805T ATE353956T1 (de) 1996-12-13 1997-12-11 Methoden zur virus-reinigung

Country Status (9)

Country Link
EP (2) EP1679368B1 (de)
JP (3) JP2001506126A (de)
AT (2) ATE353956T1 (de)
AU (1) AU5370598A (de)
CA (1) CA2274876A1 (de)
DE (2) DE69739961D1 (de)
ES (2) ES2283032T3 (de)
IL (1) IL130198A (de)
WO (1) WO1998026048A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732129B1 (en) 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
US20060275781A1 (en) 2004-11-03 2006-12-07 Introgen Therapeutics Inc. Novel method for the protection and purification of adenoviral vectors
JP4492826B2 (ja) 1996-11-20 2010-06-30 イントロジェン セラピューティクス，インコーポレイテッド アデノウイルスベクターの産生および精製のための改良された方法
US6689600B1 (en) 1998-11-16 2004-02-10 Introgen Therapeutics, Inc. Formulation of adenovirus for gene therapy
FR2787465A1 (fr) * 1998-12-21 2000-06-23 Transgene Sa Procede d'inactivation des virus enveloppes dans une preparation virale de virus non enveloppes
DE60029195T2 (de) 1999-02-22 2007-06-28 Transgene S.A. Verfahren zur Gewinnung von purifizierter Virenzusammensetzung
SE9904272D0 (sv) * 1999-11-25 1999-11-25 Amersham Pharm Biotech Ab A method for selective removal of a substance from samples containing compounds having nucleic acid structure
DK1501921T4 (da) 2002-04-30 2012-10-08 Oncolytics Biotech Inc Forbedrede virusrensningsmetoder
ATE500267T1 (de) 2003-07-21 2011-03-15 Transgene Sa Multifunktionelle cytokine
US7901921B2 (en) 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
WO2008039136A1 (en) 2006-09-29 2008-04-03 Ge Healthcare Bio-Sciences Ab Separation matrix for viral purification
US8420103B2 (en) 2007-01-30 2013-04-16 Transgene S.A. Papillomavirus vaccines
JP2010193720A (ja) * 2009-02-23 2010-09-09 Asahi Kasei Chemicals Corp アニオン交換基が固定された多孔膜を用いたウイルスの分離方法
KR20120052352A (ko) 2009-08-07 2012-05-23 트랜스진 에스.에이. Ｈｂｖ 감염을 치료하는 조성물
GB201011502D0 (en) * 2010-07-08 2010-08-25 Glaxosmithkline Biolog Sa Novel process
BR112013014457A8 (pt) 2010-12-09 2017-12-19 Pasteur Institut usos da enzima 6-metilguanina-dna-metiltrasferase (mgmt, ec 2.1.1.63) para aumentar a produção de proteína heteróloga, bem como vetor de expressão, células recombinantes e polipeptídeo de fusão compreendendo sinal de secreção peptídica e proteína snap
TWI575070B (zh) 2011-07-12 2017-03-21 傳斯堅公司 Ｈｂｖ聚合酶突變體
TW201321016A (zh) 2011-09-29 2013-06-01 Transgene Sa 免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（二）
TW201318637A (zh) 2011-09-29 2013-05-16 Transgene Sa 免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（一）
IN2015DN02055A (de) 2012-09-17 2015-08-14 Grace W R & Co
WO2014066443A1 (en) 2012-10-23 2014-05-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
EP3256156B1 (de) 2015-02-13 2025-02-12 Transgene Immunotherapeutischer impfstoff und antikörperkombinationstherapie
WO2016131945A1 (en) 2015-02-20 2016-08-25 Transgene Sa Combination product with autophagy modulator
CA3023022A1 (en) 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
EP3522920A2 (de) 2016-10-10 2019-08-14 Transgene SA Immuntherapeutisches produkt und mdsc-modulator-kombinationstherapie
JP7078620B2 (ja) 2016-11-16 2022-05-31 イミュノミック セラピューティックス， インコーポレイテッド アレルギーの治療のための核酸
EP4512477A3 (de) 2017-04-22 2025-06-11 Immunomic Therapeutics, Inc. Verbesserte lampenkonstruktionen
CN110913892A (zh) 2017-05-02 2020-03-24 免疫治疗有限公司 包含癌抗原的lamp(溶酶体相关膜蛋白)构建物
US11603527B2 (en) * 2017-12-27 2023-03-14 Global Life Sciences Solutions Usa Llc Method and kit for viral vector isolation
CA3100004A1 (en) 2018-05-15 2019-11-21 Immunomic Therapeutics, Inc. Improved lamp constructs comprising allergens
CA3113648A1 (en) 2018-09-21 2020-03-26 University Of Connecticut Compositions and methods to restore paternal ube3a gene expression in human angelman syndrome
GB201820806D0 (en) 2018-12-20 2019-02-06 Ge Healthcare Bioprocess R&D Ab Large pore agarose
TWI852977B (zh) 2019-01-10 2024-08-21 美商健生生物科技公司 前列腺新抗原及其用途
WO2021011436A1 (en) * 2019-07-12 2021-01-21 Sangamo Therapeutics, Inc. Separation and quantification of empty and full viral capsid particles
WO2021077051A1 (en) 2019-10-18 2021-04-22 Immunomic Therapeutics, Inc Improved lamp constructs comprising cancer antigens
AU2020385683A1 (en) 2019-11-18 2022-06-30 Janssen Biotech, Inc. Vaccines based on mutant CALR and JAK2 and their uses
TW202144389A (zh) 2020-02-14 2021-12-01 美商健生生物科技公司 在多發性骨髓瘤中表現之新抗原及其用途
TW202144388A (zh) 2020-02-14 2021-12-01 美商健生生物科技公司 在卵巢癌中表現之新抗原及其用途
JP2023521194A (ja) 2020-04-13 2023-05-23 ヤンセン バイオテツク，インコーポレーテツド Ｐｓｍａ及びｓｔｅａｐ１ワクチン並びにそれらの使用
US20230024133A1 (en) 2020-07-06 2023-01-26 Janssen Biotech, Inc. Prostate Neoantigens And Their Uses
WO2022009051A1 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. A method for determining responsiveness to prostate cancer treatment
WO2022009052A2 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. Prostate neoantigens and their uses
US12497598B2 (en) 2020-07-17 2025-12-16 Hvidovre Hospital Method of purifying whole virus particles
EP4508071A1 (de) 2022-04-10 2025-02-19 Immunomic Therapeutics, Inc. Bicistronische lampenkonstrukte mit immunreaktionserhöhenden genen und verfahren zur verwendung davon
WO2025158316A1 (en) 2024-01-26 2025-07-31 Janssen Biotech, Inc. Ovarian neoantigens and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248075B (it) * 1991-06-18 1995-01-05 Sclavo Spa Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.
FR2696748B1 (fr) 1992-10-14 1994-12-30 Pasteur Merieux Serums Vacc Procédé de préparation d'antigènes et de vaccins de l'hépatite A (HAV).
SK283703B6 (sk) 1993-10-25 2003-12-02 Canji, Inc. Rekombinantný adenovírusový vektor a jeho použitie
AU722196B2 (en) 1995-08-30 2000-07-27 Genzyme Corporation Chromatographic purification of adenovirus and AAV
CZ438398A3 (cs) 1996-07-01 1999-03-17 Rhone-Poulenc Rorer S. A. Způsob přípravy rekombinantních adenovirů

Also Published As

Publication number Publication date
EP0948601A1 (de) 1999-10-13
ES2349046T3 (es) 2010-12-22
JP2001506126A (ja) 2001-05-15
JP2009022292A (ja) 2009-02-05
EP1679368A1 (de) 2006-07-12
DE69739961D1 (de) 2010-09-23
CA2274876A1 (en) 1998-06-18
EP0948601B1 (de) 2007-02-14
DE69737364T2 (de) 2007-11-29
AU5370598A (en) 1998-07-03
DE69737364D1 (de) 2007-03-29
ATE353956T1 (de) 2007-03-15
WO1998026048A1 (en) 1998-06-18
EP1679368B1 (de) 2010-08-11
IL130198A (en) 2005-09-25
IL130198A0 (en) 2000-06-01
ES2283032T3 (es) 2007-10-16
JP2005318898A (ja) 2005-11-17

Similar Documents

Publication Publication Date Title
DE69737364D1 (de) Methoden zur virus-reinigung
DE60139614D1 (de) Verfahren zur s.i.p/h.323-zusammenarbeit
DE69707849D1 (de) Verfahren zur reinigung von 1,4-butandiol
DE69323983D1 (de) Methode zur Modifizierung des Fettdruckes von Buchstaben
ID16276A (id) Alat pengeluaran untuk mesin penyejuk udara.
DE69715234D1 (de) Verfahren zur reinigung von 1,1-difluorethan
EP0683595A3 (de) Vorrichtung zur Erzeugung eines Bildes.
DE69710078D1 (de) Verfahren zur reinigung von 1,1,1,3,3-pentafluorpropan
DE69723153D1 (de) Elektronen-emittierende Vorrichtung.
DE69530599D1 (de) Methode zur reinigung von keratinocyten-wachstumsfaktoren
DE69521528D1 (de) Methode zur überwachung der entfernung von schlacken
DE69836703D1 (de) Vorrichtung zur Bierfiltration
EP0588057A3 (de) Verfahren zur Optimierung des Arbeitsvorgangs eines Elektrohandwerkzeugs.
DE50011778D1 (de) Vorrichtung zur regeneration von raumluft
DE69719790D1 (de) Vorrichtung zur reduzierung des bodensogs von geschossen
DE69112391D1 (de) Verfahren zur reinigung von fluorwasserstoff.
TR199501263A2 (tr) Agiz yoluyla alinan sabeluzol süspansiyonlari.
DE122006000019I2 (de) Methode zur reinigung von keratinocyten-wachstumsfaktoren
ITTO940513A0 (it) Fanale per veicoli.
IT236070Y1 (it) Luce per veicoli industriali.
ID16843A (id) Alat pembersih.
DE19781134T1 (de) Vorrichtung zur Wiederherstellung des Synchronzustandes
DE69505947D1 (de) Vorrichtung zur reinigung von luft
DE59909959D1 (de) Verfahren zur aufreinigung von (+-)2-azabicyclo (2.2.1)hept-5-en-3-on
FI962626A0 (fi) Menetelmä hiokkeen valmistusprosessin ohjaamiseksiMenetelmä hiokkeen valmistusprosessin ohjaamiseksi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties